HI
TEVA icon

Horizon Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Horizon Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
45,561
+9,751
+27% +$325K 0.02% 605
2026
Q1 		$1.08M Buy
35,810
+9,586
+37% +$308K 0.01% 635
2025
Q4 		$818K Buy
+26,224
New +$646K 0.01% 687

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Horizon Investments's TEVA Position: Q2 2026 in Review

Horizon Investments increased its Teva Pharmaceuticals (TEVA) stake by 27% in Q2 2026, buying an estimated $325K and bringing the position to 45,561 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #605.

Horizon Investments first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Horizon Investments held 45,561 shares of Teva Pharmaceuticals worth $1.54M as of Q2 2026.
  • Horizon Investments bought 9,751 Teva Pharmaceuticals shares in Q2 2026, an estimated $325K.
  • Teva Pharmaceuticals made up 0.02% of Horizon Investments's portfolio in Q2 2026, its #605 holding.
  • Horizon Investments first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.